Lupin LimitedNSE: LUPIN

Press Release Dec 27 2023

· Issued by Lupin Limited

Lupin Limited has informed the Exchange regarding a press release dated December 27, 2023, titled "Lupin Receives Approval from U.S. FDA for Loteprednol EtabonateOphthalmic Suspension, 0.2%.".

View Attachment